U.S. market Closed. Opens in 7 hours 52 minutes

RPID | Rapid Micro Biosystems, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
Revenue22.52M17.13M23.23M16.08M16.51M
Cost of Revenue28.00M25.67M30.97M24.15M16.75M
Gross Profit-5.49M-8.54M-7.74M-8.07M-234.00K
Operating Expenses51.08M54.68M39.49M22.47M18.40M
Selling, General & Admin38.26M41.81M29.71M15.94M12.97M
Research & Development12.82M12.87M9.78M6.53M5.43M
Other Operating Expenses-83.00K59.00K-808.00K22.00K16.00K
Operating Income-56.56M-63.22M-47.23M-30.54M-18.63M
Other Expenses / Income4.13M1.84M-26.20M-6.40M-2.11M
Before Tax Income-52.44M-61.38M-73.43M-36.94M-20.74M
Income Tax Expenses31.00K-576.00K91.00K134.00K427.00K
Net Income-52.47M-60.81M-73.52M-37.08M-21.17M
Interest ExpensesN/A1.78M2.65M3.45M2.38M
Basic Shares Outstanding43.02M42.45M41.47M38.67M39.66M
Diluted Shares Outstanding43.02M42.45M41.47M38.67M39.66M
EBITDA-53.46M-63.22M-46.51M-29.01M-17.16M
EBITDA Margin-237.39%-368.99%-200.20%-180.44%-103.91%
EBIT-52.44M-59.60M-70.78M-33.50M-18.37M
EBIT Margin-232.85%-347.89%-304.68%-208.35%-111.25%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙